HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,564,750 | +43.8% | 27,500 | 0.0% | 0.02% | +60.0% |
| Q3 2022 | $1,088,000 | -47.4% | 27,500 | -46.9% | 0.02% | -40.0% |
| Q1 2022 | $2,068,000 | +13.9% | 51,800 | +29.5% | 0.02% | +4.2% |
| Q2 2021 | $1,816,000 | -55.0% | 40,000 | -58.7% | 0.02% | -72.4% |
| Q1 2021 | $4,035,000 | +86.8% | 96,800 | -19.3% | 0.09% | -28.7% |
| Q1 2020 | $2,160,000 | -66.5% | 120,000 | -67.0% | 0.12% | -43.5% |
| Q4 2019 | $6,446,000 | +109.6% | 363,500 | +83.4% | 0.22% | +34.2% |
| Q3 2019 | $3,076,000 | +496.1% | 198,200 | +560.7% | 0.16% | +519.2% |
| Q2 2019 | $516,000 | +13.7% | 30,000 | +20.0% | 0.03% | +4.0% |
| Q3 2018 | $454,000 | -97.9% | 25,000 | -97.6% | 0.02% | -98.9% |
| Q4 2017 | $21,429,000 | – | 1,057,700 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |